{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:31:08Z","timestamp":1792654268035,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["18CVD05"],"award-info":[{"award-number":["18CVD05"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL133272"],"award-info":[{"award-number":["R01 HL133272"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL130020"],"award-info":[{"award-number":["R01 HL130020"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17MERIT3361009"],"award-info":[{"award-number":["17MERIT3361009"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["IRSA 1015009"],"award-info":[{"award-number":["IRSA 1015009"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.stemcr.2020.11.010","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T05:33:29Z","timestamp":1608269609000},"page":"168-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles"],"prefix":"10.1016","volume":"16","author":[{"given":"Joe Z.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadjet","family":"Belbachir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajani","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2020.11.010_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","article-title":"A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes","volume":"84","author":"Ando","year":"2017","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.stemcr.2020.11.010_bib2","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.stemcr.2018.04.005","article-title":"Electrophysiologic characterization of calcium handling in human induced pluripotent stem cell-derived atrial cardiomyocytes","volume":"10","author":"Argenziano","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.stemcr.2020.11.010_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vascn.2017.02.021","article-title":"Proarrhythmia liability assessment and the comprehensive in\u00a0vitro proarrhythmia assay (CiPA): an industry survey on current practice","volume":"86","author":"Authier","year":"2017","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.stemcr.2020.11.010_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4149\/gpb_2010_03_309","article-title":"Drug-induced changes in action potential duration are proportional to action potential duration in rat ventricular myocardium","volume":"29","author":"Barandi","year":"2010","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.stemcr.2020.11.010_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00395-009-0082-7","article-title":"Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations","volume":"105","author":"Barandi","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib6","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2020.11.010_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/toxsci\/kfw200","article-title":"Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias","volume":"155","author":"Blinova","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.stemcr.2020.11.010_bib8","doi-asserted-by":"crossref","first-page":"101698","DOI":"10.1016\/j.scr.2019.101698","article-title":"Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties","volume":"43","author":"Brink","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.stemcr.2020.11.010_bib9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.stemcr.2020.11.010_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vascn.2012.08.167","article-title":"High throughput measurement of Ca2+ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry","volume":"66","author":"Cerignoli","year":"2012","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.stemcr.2020.11.010_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrcardio.2016.36","article-title":"Induced pluripotent stem cells: at the heart of cardiovascular precision medicine","volume":"13","author":"Chen","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib41","first-page":"815761.3","article-title":"A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells","author":"Chen","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.stemcr.2020.11.010_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.scr.2015.08.002","article-title":"Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells","volume":"15","author":"Chen","year":"2015","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.stemcr.2020.11.010_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The comprehensive in\u00a0vitro proarrhythmia assay (CiPA) initiative- update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.stemcr.2020.11.010_bib14","doi-asserted-by":"crossref","first-page":"e1003543","DOI":"10.1371\/journal.pcbi.1003543","article-title":"Comprehensive analyses of ventricular myocyte models identify targets exhibiting favorable rate dependence","volume":"10","author":"Cummins","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib15","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1161\/01.CIR.0000147541.49575.15","article-title":"Images in cardiovascular medicine. Drug-induced long-QT syndrome with macroscopic T-wave alternans","volume":"110","author":"Grabowski","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2020.11.010_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/toxsci\/kft205","article-title":"Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model","volume":"136","author":"Guo","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.stemcr.2020.11.010_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yjmcc.2014.09.010","article-title":"Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: correlation and complementarity with extracellular electrophysiology","volume":"77","author":"Hayakawa","year":"2014","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/toxsci\/kfw171","article-title":"The use of ratiometric fluorescence measurements of the voltage sensitive dye di-4-ANEPPS to examine action potential characteristics and drug effects on human induced pluripotent stem cell-derived cardiomyocytes","volume":"154","author":"Hortigon-Vinagre","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.stemcr.2020.11.010_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.yjmcc.2015.05.003","article-title":"Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories","volume":"85","author":"Hwang","year":"2015","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1933719110385130","article-title":"Cryopreservation of human embryonic stem cells derived-cardiomyocytes induced by BMP2 in serum-free condition","volume":"18","author":"Kim","year":"2011","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.stemcr.2020.11.010_bib21","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.118.037357","article-title":"Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer","volume":"139","author":"Kitani","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2020.11.010_bib22","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1111\/bph.13713","article-title":"Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes","volume":"174","author":"Kopljar","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib23","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.stemcr.2018.11.007","article-title":"Development of a human iPSC cardiomyocyte-based scoring system for cardiac hazard identification in early drug safety de-risking","volume":"11","author":"Kopljar","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.stemcr.2020.11.010_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCRESAHA.118.314202","article-title":"Identifying the transcriptome signatures of calcium channel blockers in human induced pluripotent stem cell-derived cardiomyocytes","volume":"125","author":"Lam","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.stemcr.2020.11.010_bib25","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells","volume":"138","author":"Ma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.stemcr.2020.11.010_bib26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3389\/fphar.2018.01035","article-title":"Experimentally validated pharmacoinformatics approach to predict hERG inhibition potential of new chemical entities","volume":"19","author":"Munawar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yrtph.2017.06.006","volume":"88","author":"Nozaki","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/pr.116.013003","article-title":"Patient and disease\u2013specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics","volume":"72","author":"Paik","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.stemcr.2020.11.010_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-2193-5_1","article-title":"Principles of cryopreservation","volume":"1257","author":"Pegg","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/toxsci\/kft005","article-title":"Phenotypic profiling of structural cardiotoxins in\u00a0vitro reveals dependency on multiple mechanisms of toxicity","volume":"132","author":"Pointon","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.stemcr.2020.11.010_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-3-319-45457-3_10","article-title":"Cryopreservation of human pluripotent stem cell-derived cardiomyocytes: strategies, challenges, and future directions","volume":"951","author":"Preininger","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM199401273300402","article-title":"Electrical alternans and vulnerability to ventricular arrhythmias","volume":"330","author":"Rosenbaum","year":"1994","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stemcr.2020.11.010_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium","volume":"167","author":"Sager","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.stemcr.2020.11.010_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2020.11.010_bib34","doi-asserted-by":"crossref","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","article-title":"WITHDRAWN--a resource for withdrawn and discontinued drugs","volume":"44","author":"Siramshetty","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.stemcr.2020.11.010_bib35","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/scd.2014.0533","article-title":"Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?","volume":"24","author":"Veerman","year":"2015","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.stemcr.2020.11.010_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCRESAHA.110.223586","article-title":"Alternans and arrhythmias","volume":"108","author":"Weiss","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.stemcr.2020.11.010_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/rme.10.91","article-title":"Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells","volume":"6","author":"Xu","year":"2011","journal-title":"Regen. Med."},{"key":"10.1016\/j.stemcr.2020.11.010_bib43","first-page":"105","article-title":"Effect of cryopreservation on cell proliferation and immunogenicity of transplanted human heart cells","volume":"16","author":"Yokomuro","year":"2010","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.stemcr.2020.11.010_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.copbio.2018.03.002","article-title":"Applications of genetically engineered human pluripotent stem cell reporters in cardiac stem cell biology","volume":"52","author":"Zhang","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.stemcr.2020.11.010_bib39","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.stem.2019.02.015","article-title":"A human iPSC double-reporter system enables purification of cardiac lineage subpopulations with distinct function and drug response profiles","volume":"24","author":"Zhang","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2020.11.010_bib40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.stemcr.2018.01.002","article-title":"Comparison of non-human primate versus human induced pluripotent stem cell-derived cardiomyocytes for treatment of myocardial infarction","volume":"10","author":"Zhao","year":"2018","journal-title":"Stem Cell Rep."}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671120304586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671120304586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:18:59Z","timestamp":1778858339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671120304586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213671120304586"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2020.11.010","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2020.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}